Increased CAIX expression is associated with an aggressive phenotype and predicts poor outcomes in breast, cervical, non-small cell lung, esophageal, and gastric cancer [18,20,22,25,26,28,31,32,34]. This evidence concerns the gene CA9 and gastric cancer.